Home/Filings/4/0001209191-22-047297
4//SEC Filing

Tokman Alexander Y 4

Accession 0001209191-22-047297

CIK 0001681682other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 8:55 AM ET

Size

4.6 KB

Accession

0001209191-22-047297

Insider Transaction Report

Form 4
Period: 2022-08-22
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-08-22$0.26/sh+20,000$5,200152,857 total

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001334483

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 8:55 AM ET
Size
4.6 KB